{"id":"W4412690588","doi":"10.1093/neuonc/noaf164","title":"Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Université de Montréal; Sunnybrook Health Science Centre; Centre Hospitalier Universitaire Sainte-Justine","funders":"Medac; Servier; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Erasmus Universiteit Rotterdam; Springworks Therapeutics; Novocure; Alexion Pharmaceuticals; Eisai; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Pfizer","keywords":"Counterpoint; Mutant; Oncology; Medicine; Internal medicine; Cancer research; Biology; Psychology; Genetics; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001563243,0.0003067299,0.0006778237,0.000380347,0.0001468629,0.00002995094,0.0001014836,0.0002778452,0.0001316271],"category_scores_gemma":[0.000462968,0.0002619437,0.0002565134,0.0003427344,0.0001133926,0.00009484229,0.00008969875,0.0002452391,0.00009067674],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005668596,"about_ca_system_score_gemma":0.0003082624,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000132641,"about_ca_topic_score_gemma":0.0002847174,"domain_scores_codex":[0.9980142,0.0001089433,0.0005399138,0.0006263535,0.0002070268,0.0005035558],"domain_scores_gemma":[0.998397,0.0004922251,0.0001713492,0.0004355363,0.0003215097,0.000182361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001099735,0.003685602,0.002915528,0.0002374149,0.0003537148,0.002147829,0.0002882858,0.00001218148,0.8546566,0.02360241,0.08322509,0.02777557],"study_design_scores_gemma":[0.02750165,0.007300708,0.009346358,0.0003409293,0.001022245,0.0008978599,0.0003004582,0.000688424,0.6480694,0.00531259,0.2988125,0.0004068463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9216581,0.0003855764,0.0005026112,0.07021608,0.001778728,0.001960122,0.00009965229,0.0002013577,0.003197746],"genre_scores_gemma":[0.9774359,0.0001428235,0.0008506223,0.02031806,0.0003012931,0.0006532785,0.0001561423,0.00004476446,0.00009704376],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2155874,"threshold_uncertainty_score":0.9999833,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01230442653714137,"score_gpt":0.29382266277975,"score_spread":0.2815182362426086,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}